Comparison 24. CPA 2 mg / EE 50 µg versus minocycline hydrochloride 50 mg.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Women with self‐assessed acne improvement at cycle 6	1	78	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.48 [0.43, 5.01]
2 Women with self‐assessed lack of acne at cycle 6	1	78	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.85 [0.28, 2.60]
3 Discontinuation due to non‐acne adverse event	1	98	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.36 [0.29, 6.26]
4 Discontinuation due to lack of acne improvement	1	98	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.66 [0.11, 3.95]